171. Crossing the Line of Gram-Negative Resistance
Friday, October 28, 2016: 2:00 PM-3:30 PM
Room: 293-296

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • address the current diagnostic and treatment challenges presented by Multidrug Resistant Gram Negative Bacteria
  • describe the mechanism by which resistance to “last line antimicrobial agents” develops 
  • develop individualized therapeutic strategies to mitigate the emergence of resistance and to improve clinical outcomes

Target Audience: Clinicians, Hospital epidemiologists, Infection preventionists, Lab personnel, Pharmacists, TBD

Tracks: Pediatric ID, Epidemiology and Infection Control, Adult ID

Moderators:  Cesar Arias, MD, PhD, FIDSA, Univ. El Bosque and Robert A. Bonomo, MD, Case Western Reserve University

2:00 PM
2:25 PM
2:30 PM
Polymyxin Resistance
Federico Perez, MD

2:55 PM
3:00 PM
Tigecycline Resistance in KPC
Mary Bessesen, MD

3:25 PM

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours .15 of pharmacy CE

ACPE Number: 0221-9999-16-269-L01-P


C. Arias, None

R. A. Bonomo, Merck: Grant Investigator , Research grant
Wockhardt: Grant Investigator , Grant recipient
Allergan: Grant Investigator , Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.